tiprankstipranks
Trending News
More News >

Ruxandra Draghia-Akli Insider Profile

11 Followers
Ruxandra Draghia-Akli, EVP, Research & Development at Novavax, holds 23.56K shares in Novavax (Ticker: NVAX).
tipranks
Ruxandra Draghia-Akli

Ruxandra Draghia-Akli
Novavax (NVAX)
EVP, Research & Development

Not Ranked
Ruxandra Draghia-Akli has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$229K
100.00%
A breakdown of Ruxandra Draghia-Akli's holdings

Insider Roles

Novavax
(NVAX)
EVP, Research & Development
Roles that Ruxandra Draghia-Akli holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Ruxandra Draghia-Akli

Ruxandra Draghia-Akli's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Novavax
Mar 05, 2026
EVP, Research & Development
Uninformative Buy
145.71K
$229.03K
Ruxandra Draghia-Akli has not reported any informative transactions for NVAX, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 13, 2025
Uninformative Buy
$60.75K
8,209
$7.40
Mar 05, 2026
Uninformative Buy
$145.71K
15,354
$9.49
List of latest transactions for each holding click on a transaction to see Ruxandra Draghia-Akli's performance on stock

Ruxandra Draghia-Akli insider profile FAQ

What is the percentage of profitable transactions made by Ruxandra Draghia-Akli?
The percentage of profitable transactions made by Ruxandra Draghia-Akli is ―.
    What is the average return per transaction made by Ruxandra Draghia-Akli?
    The average return per transaction made by Ruxandra Draghia-Akli is ―.
      What stocks does Ruxandra Draghia-Akli hold?
      Ruxandra Draghia-Akli holds: NVAX stocks.
        What was Ruxandra Draghia-Akli’s latest transaction?
        Ruxandra Draghia-Akli latest transaction was an Uninformative Buy of $145.71K.
          What was Ruxandra Draghia-Akli's most profitable transaction?
          Ruxandra Draghia-Akli’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Ruxandra Draghia-Akli's role in Novavax?
            Ruxandra Draghia-Akli's role in Novavax is EVP, Research & Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.